These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1077 related items for PubMed ID: 12522770

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
    Al-Yatama MK, Mustafa AS, Al-Kandari FM, Khaja N, Zohra K, Monem RA, Abraham S.
    Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
    [Abstract] [Full Text] [Related]

  • 24. Fetal blood group genotyping: present and future.
    Daniels G, Finning K, Martin P, Summers J.
    Ann N Y Acad Sci; 2006 Sep; 1075():88-95. PubMed ID: 17108196
    [Abstract] [Full Text] [Related]

  • 25. Noninvasive fetal RhCE genotyping from maternal blood.
    Geifman-Holtzman O, Grotegut CA, Gaughan JP, Holtzman EJ, Floro C, Hernandez E.
    BJOG; 2009 Jan; 116(2):144-51. PubMed ID: 18503573
    [Abstract] [Full Text] [Related]

  • 26. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K, Martin P, Daniels G.
    Methods Mol Biol; 2009 Jan; 496():143-57. PubMed ID: 18839110
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis.
    Clausen FB, Christiansen M, Steffensen R, Jørgensen S, Nielsen C, Jakobsen MA, Madsen RD, Jensen K, Krog GR, Rieneck K, Sprogøe U, Homburg KM, Grunnet N, Dziegiel MH.
    Transfusion; 2012 Apr; 52(4):752-8. PubMed ID: 21995641
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.
    Daniels G, Finning K, Martin P, Soothill P.
    Vox Sang; 2004 Nov; 87(4):225-32. PubMed ID: 15585017
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Non-invasive prenatal determination of fetal RhD genotyping from maternal plasma: a preliminary study in Pakistan.
    Mohammed N, Kakal F, Somani M, Zafar W.
    J Coll Physicians Surg Pak; 2010 Apr; 20(4):246-9. PubMed ID: 20392400
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Non invasive prenatal genetic diagnosis of fetal RhD and sex through the analysis of free fetal DNA in maternal plasma].
    Sesarini C, Giménez ML, Redal MA, Izbizky G, Aiello H, Argibay P, Otaño L.
    Arch Argent Pediatr; 2009 Oct; 107(5):405-9. PubMed ID: 19809760
    [Abstract] [Full Text] [Related]

  • 40. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium.
    Minon JM, Gerard C, Senterre JM, Schaaps JP, Foidart JM.
    Transfusion; 2008 Feb; 48(2):373-81. PubMed ID: 18039319
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.